Sign in
4

Changes in Ownership

AIM ImmunoTech Inc. Filed Acc 0001450324-18-000004

Options or other derivatives

  • Exec. Vice Chairman/CEO/Pres. acquired 161,290 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

EQUELS THOMAS K. · Exec. Vice Chairman/CEO/Pres.

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2018-07-18 Grant or award : show line 1 in the form Options to buy Common Stock +161,290 161,290 D
Loading xslF345X03/primary_doc.xml…